Xcout Intel
Broken String Biosciences
Broken String Biosciences is a biotechnology research company headquartered in Cambridge, England, operating out of Little Chesterford. The company develops advanced platforms dedicated to powering the future of gene editing safety and development.
Subscribe to see Broken String Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Broken String Biosciences at a glance
Broken String Biosciences is a life sciences company headquartered in United Kingdom. Its most recent funding round, Series A, raised $15M in September 2023. Xcout tracks 12 named people at Broken String Biosciences, including Gabe Longoria (Chief Commercial Officer).
Broken String Biosciences leadership
- Gabe LongoriaChief Commercial Officer
- Samantha MacroChief Finance Officer
- Felix DobbsCo-founder, Chief Executive Officer
- Simon ReedCo-founder, Chief Scientific Officer
- Patrick van EijkCo-founder, Staff Scientist
- Claire DacombeVP Sales APAC & EU
6 more named people on record for Broken String Biosciences, with roles, board committees and tenure — see the full roster →
Broken String Biosciences funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $15M | 7 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Get Broken String Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Broken String Biosciences in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access